Press
Releases
July
27, 2010—Aphios
Awarded United
States Patent for Compositions and
Methods for Inhibiting 5-Alpha Reductase
June
23, 2010—Aphios
Awarded United States Patent for Polymer Drug Delivery Nanotechnology
Platform
December
08, 2009—Aphios
Receives Frost & Sullivan Best Practices Award
September
30, 2009—Aphios
Awarded NIH ARRA Challenge Grant for Pathogen Inactivation
Technology for Blood Products
May
26, 2009—Aphios
Announces Presentation of Phase II/III Clinical Trial Data
on Zindol® for Cancer Chemotherapy Induced Nausea
April
07, 2009—Aphios
Granted Japanese Patent for Inactivating Viruses and Other
Pathogens in Biologics and Human Plasma
March
31, 2009—National
Cancer Institute (NCI) Contracts with Aphios to Develop
Nannotech Combination Therapy for Certain Cancers
March
24, 2009—Aphios
Corporation Executes Collaborative R&D Agreement with
VivaCell Biotechnology España to Develop Combination
Therapy for HIV Latency
March
17, 2009—Aphios
Corporation License IP from Louisiana State University for
Chronic Iinflammation and Organ Transplatation Rejection
October
28, 2008—Aphios
Awarded SBIR Grant from National Institute on Drug Abuse
(NIDA) for Nanotech Formulation of D9-THC for Marijuana
Addiction and Other Unmet Medical Needs
May
29, 2008—Aphios
Corporation Awarded Japanese Patent for Phospholipid Nanosomes
Technology Platform
September
18, 2007 —
Aphios
Awarded STTR Grant from NCI for Nanosomal Formulation of
Novel, Nontoxic Vitamin D Analog for Hormone Refractory
Prostate Cancer
February
19, 2007 —
Aphios
Awarded United States Patent for Polymer Nanospheres Technology
Platform
June
13, 2006 —
Aphios
Awarded United States Patent for Antiviral Therapeutics
May
09, 2006 —
Aphios
Awarded United States Patent for Vaccines for HIV/AIDS,
Influenza and Other Infectious Diseases
February
27, 2006 —Aphios
Corporation Awarded Japanese Patent for Phospholipid Nanosomes
January
18, 2006 —
Amyxa Pharmaceutials
to Develop Novel Anti-Influenza Drug from Marine Microorganisms
and Medicinal Plants
January
17, 2006 —
Boston
Buisness Journal: Bird Flu Prompts Local R&D
December
13, 2005 —
Aphios Corporation Announces
Licensing of Non-Toxic Vitamin D Analog for Prostate Cancer
from Boston University Medical School
November
14, 2005 —
Mass
High Tech:
Woburn Marine Tech Firm Links with Maine Co., Seeks Growth
Funding
July
19, 2005 —
Aphios Corporation
Announces Collaboration with Japanese Companies for Development
of Orally-Bioavilable Anti-Cancer Therapeutic
November
17, 2004—
Aphios Corporation
Announces Launch of SuperCool Gingerol for Calming Stomachs
and Healthy Digestion
July
13, 2004 — Aphios
Corporation Announces Launch of SuperCool St. John for Emotional
Well-Being, Relaxed Outlook and Positive Mood
April
19, 2004 — Mass
High Tech: Nature's Way The Case For, Against Natural Therapeutics
March
23, 2004 — Mass
High Tech: Aphios Wins Substantial NIH Grant to Study Potential
HIV Therapies
March
23, 2004 — Aphios
Corporation Awarded Innovative Research Grant from National
Institute of Allergy & Infectious Diseases, NIH to Develop
Novel Anti-HIV Therapeutics
March
16, 2004 — Aphios
Corporation Executes Material Transfer Agreement with National
Cancer Institute, NIH for Natural Products to Discover and
Develop Novel Anticancer and Antiviral Therapeutics
September
19, 2003 — Natural
High: Aphios Profits by Taming Wild Compounds; Boston Business
Journal
September
09, 2003 — Aphios
Corporation Awarded National Institutes of Health SBIR Grant
to Develop Novel Anti-Smallpox Therapeutics
September
03, 2003 — Aphios
Corporation Executes Cooperative Agreement with NIH and
USAMRID For Discovery of Novel Therapeutics Against SARS
and Other Coronaviruses
June
03, 2003 — Aphios
Corporation Granted United States Patent for Fractionation
of Biologically-Derived Materials
January
07,
2003 — Aphios
Corporation awarded National Institutes of Health Grant
for Development of Novel Anti-Influenza Drugs
December
11, 2002
— Aphios
granted European Patent for Nanoencapsulation of Cancer
Drugs
November
04, 2002
— Aphios
granted US Patent for Inactivating Viruses and Other Pathogens
in Human Plasma and Blood Products
June
13,
2002
— Aphios Corporation
High on Possibility of Treating Hunger Loss; Woburn Advocate
June
04,
2002
— Aphios Awarded National
Cancer Institute Grant for Developing Natural Cannabinoid
Products for Medical Use
May
07, 2002
— Aphios
Awarded NCI Contract for Manufacturing and Formulation of
Natural Anticancer Drug for Melanoma Clinical Trials
October
24, 2001
— Aphios Granted
United States Patent for Making an Enhanced St. John’s Wort
Product
July
17, 2001
— Aphios Awarded Contract
from National Cancer Institute for Isolation of Natural
Anticancer Drugs
June
20,
2001
— Aphios and
ITC/Immune Technology to Collaborate on Natural Therapuetic
for Chronic Hepatitis C
May
07, 2001
— Aphios
Granted United States Patent for the Crystallization of
Complex Molecules such as Taxol
February
19,
2001
— Time-release
Technology for HIV Vaccine Draws Grant; Mass High Tech
January
29,
2001
— Aphios Awarded
Grant from NIAID, NIH for Development of Controlled Release
HIV Vaccine Adjuvant
December
19, 2000
— Aphios Awarded
SBIR Grant from FDA For Development of a Virus Inactivation
Medical Device
November
28, 2000
— Aphios Awarded
SBIR Grant from NIGMS, NIH for Development of a Natural
Virus-Free Fibrin Sealant
October
10, 2000
— Aphios awarded
SBIR Grant from NIH for Development of Natural Marine Anti-Plaque
Compound
October
03, 2000
— Aphios awarded
SBIR grant from NCCAM, NIH for Standardized & Improved
Saw Palmetto Product
September
13, 2000
— Aphios
Corporation Granted European Patent for Inactivating Viruses
May
23, 2000
— Aphios Corporation
Granted Chinese Patent For Isolation of Taxol® from
Yew Needles
May
11, 2000
— Aphios Corporation
Awarded Phase II SBIR Grant from NCCAM, NIH for Improved
St. John’s Wort Product
November
03, 1999
— Aphios Corporation
Awarded Fast-Track SBIR Grant from NIH for Improved St.
John’s Wort Product
September
28, 1999
— Aphios
Corporation Awarded SBIR Grant from NIH for Solvent-Free
Protein Comminution
June
29, 1999
— Aphios
Corporation Granted United States Patent for Drug Manufacturing
Process Rapidly and Selectively Manufactures Truly “Green”
Medicines
June
02, 1999
— Aphios
Corporation Granted United States Patent for Drug Delivery
Technique Reduces Toxicity and Improves Efficacy of Taxol
®
May
18, 1999
— Aphios Corporation
Granted United States Patent for Virus Inactivation Drug
SafetyTechnique
May
11, 1999
— Aphios Corporation
Granted United States Patent for Drug Discovery Technique
August
10, 1998
— Aphios Corporation Granted
NIH Support for Development of Novel HIV Therapeutic Vaccine
